Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2005-11-22
2008-09-23
Goldberg, Jeanine A (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200, C536S023100, C536S024300
Reexamination Certificate
active
07427482
ABSTRACT:
The invention concerns the genomic sequence of the purH gene. The invention also concerns biallelic markers of a purH gene and the association established between these markers and cancer, particularly prostate cancer. The invention provides means to determine the predisposition of individuals to cancer as well as means for the diagnosis of cancer and for the prognosis/detection of an eventual treatment response to agents acting on cancer.
REFERENCES:
patent: 5719032 (1998-02-01), Vielkind
patent: 6544737 (2003-04-01), Blumenfeld et al.
patent: 2003/0092019 (2003-05-01), Meyer et al.
patent: 0 048 970 (1982-04-01), None
patent: WO 98/20165 (1998-05-01), None
patent: WO 98/33846 (1998-09-01), None
patent: WO 99/04038 (1999-01-01), None
patent: WO 99/04265 (1999-01-01), None
Hirschhorn et al. (Genetics in Medicine. vol. 4, No. 2, pp. 45-61, Mar. 2002).
Ioannidis (Nature Genetics, vol. 29, pp. 306-309, Nov. 2001).
Beardsley, et al., “Structure and Functional Relationships in HumanpurH,”Purine and Pyrimidine Metabolism in Man IX, (1998):221-226.
Chee, et al., “Accessing genetic information with high-density DNA arrays”,Science(1996), 274:610-614; American Association for the Advancement of Science.
Database Geneseq, Derwent Acc. No. Q77811 (Jul. 16, 1995).
Database Geneseq, Derwent Acc. No. Q93402 (Dec. 20, 1995).
Database Geneseq, Derwent Acc. No. T51562 (Nov. 6, 1997).
Database Geneseq, Derwent Acc. No. V01040 (Mar. 25, 1998).
Database Geneseq, Derwent Acc. No. T85064 (Mar. 19, 1999).
Database Geneseq, Derwent Acc. No. Z25419 (Dec. 16, 1999).
Database Empatent EMBL, Heidelberg Acc. No. A39830 (Mar. 5, 1997).
Database Empatent EMBL, Heidelberg Acc. No. I88685 (Aug. 11, 1998).
Database Empatent EMBL, Heidelberg Acc. No. I88742 (Aug. 11, 1998).
Kruglyak, L. “The use of a genetic map of biallelic markers in linkage studies”,Nature Genetics(1997), 17:21-24; Nature America, New York.
Rayl, et al., “The HumanpurH Gene Product, 5-Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase/IMP Cyclohydrolase”,J. Biol. Chem. (1996), 271(4):2225-2233.
Sapolsky, et al., “High-throughput polymorphism screening and genotyping with high-density oligonucleotide arrays”,Genetic Analysis: Biomolecular Engineering(1999), 14(5-6):187-192; Elsevier Science and Publishing, U.S.
Sugita, et al., “Characterization of Molecularly Cloned Human 5-Aminoimidazole-4-carboxamide Ribonucleotide Transformylase”,J. Biochem. (1997), 122(2):309-313.
Blumenfeld Marta
Bougueleret Lydie
Chumakov Ilya
Cohen-Akenine Annick
Goldberg Jeanine A
Saliwanchik Lloyd & Saliwanchik
Serono Genetics Institute S.A.
LandOfFree
Methods of assessing the risk for the development of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of assessing the risk for the development of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of assessing the risk for the development of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3989871